deltatrials
Recruiting OBSERVATIONAL NCT05610501

Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.

Sponsor: Charles University, Czech Republic

Updated 5 times since 2022 Last updated: Jul 1, 2024 Started: May 1, 2021 Primary completion: Apr 30, 2025 Completion: Apr 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cervical Cancer and Endometrial Cancer and is currently actively recruiting participants. Charles University, Czech Republic leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotRecruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotRecruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotRecruiting~Sep 2024 – ~Dec 2025 · 15 months · monthly snapshotRecruiting~Dec 2025 – present · 5 months · monthly snapshotRecruiting

Change History

5 versions recorded
  1. Dec 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — Dec 2025 [monthly]

    Recruiting

  3. Aug 2024 — Sep 2024 [monthly]

    Recruiting

  4. Jul 2024 — Aug 2024 [monthly]

    Recruiting

  5. Dec 2022 — Jul 2024 [monthly]

    Recruiting

    First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Charles University, Czech Republic
  • Karolinska Institutet and Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden.
  • Policlinico Universitario A. Gemelli, IRCSS, Rome, Italy.
  • UZ Leuven, Leuven, Belgium
  • Universitaire Ziekenhuizen KU Leuven
Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .